Today: 13 June 2021 RU UA EN
About Contacts
Become a member of Ukrainian integrated system of technology transfer Publish technological profile
Technologies

Сomplex biologically active drug Kardiovit for prophylaxis and treatment of cardiovascular diseases

Індентифікаційний номер: Offers
Опубліковано: 06 February 2018 Кінцева дата: 10 January 2023
Країна: Україна

Completion of preclinical tests of a preparation and searching of his potential producer is supposed. Researches have to be conducted on several models of cardiovascular pathologies for the purpose of obtaining objective data on specific effectiveness of a preparation. Registration of the hole report and documents necessary for formation of the registration file on preparation, in particular, of "Module 2.4" and "Module 2.5".


Ключові слова:

Cardiovascular diseases.


Опис пропозиції

Some natural  biologically active compounds are included  in the composition  in a particular ratio . There are  amino acid, two vitamins, microelement. The drug activates endogenic synthesis of thiamine diphosphate (cocarboxylases) in tissues and  is analog on action of the known drug "Cocarboxylase". Thanks to synergetic action of components the new drug activates and stabilizes a cellular metabolism  in a cardiac muscle. Medicinal form - tablets with a sheet covering or capsules.

Тип технології

Biotechnology

Сфера застосування

Medicine and health care: 5.3. Other medical means: 2) Pharmaceuticals / thin chemicals

Технічні та економічні переваги

Advantages of new  drug before medicine "Cocarboxylase" consist in the following: 1) Cardiovit  efficiently works at per os reception, "Cocarboxylase" can be entered into an organism only by injections; 2) the new drug has the prolonged action thanks to activation of the  limiting reactions of a cellular metabolism in tissues; 3) the new drug has to be cheaper.

Iнноваційні аспекти

Advantages of new  drug before medicine "Cocarboxylase" consist in the following: 1) Cardiovit  efficiently works at per os reception, "Cocarboxylase" can be entered into an organism only by injections; 2) the new drug has the prolonged action thanks to activation of the  limiting reactions of a cellular metabolism in tissues; 3) the new drug has to be cheaper.

Де була представлена технологія

Ukraine

Поточна стадія: Є результати експериментальних досліджень
Статус прав інтелектуальної властності: Заявка на патент

Умови співпраці:

Тип організації:

Joint further development

Регіони: Азія
Країни СНД
Південна Америка
Північна Америка
Східна Європа
Центральна Європа
Підтримка, що надається при передачі технічного проєкту:

Terms of Service


Copyright (c) ES Ukrtechinform 2017